|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Otani K, Li X, Arakawa T, Chan FK and Yu
J: Epigenetic-mediated tumor suppressor genes as diagnostic or
prognostic biomarkers in gastric cancer. Expert Rev Mol Diagn.
13:445–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim SJ, Wang YG, Lee HW, Kang HG, La SH,
Choi IJ, Irimura T, Ro JY, Bresalier RS and Chun KH: Up-regulation
of neogenin-1 increases cell proliferation and motility in gastric
cancer. Oncotarget. 5:3386–3398. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu L, Li Y, Yan D, He J and Liu D:
MicroRNA-183 inhibits gastric cancer proliferation and invasion via
directly targeting Bmi-1. Oncol Lett. 8:2345–2351. 2014.PubMed/NCBI
|
|
7
|
Sun YC, Wang J, Guo CC, Sai K, Wang J,
Chen FR, Yang QY, Chen YS, Wang J, To TS, et al: MiR-181b
sensitizes glioma cells to teniposide by targeting MDM2. BMC
Cancer. 14:6112014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen C, Zhao Z, Liu Y and Mu D:
microRNA-99a is downregulated and promotes proliferation, migration
and invasion in non-small cell lung cancer A549 and H1299 cells.
Oncol Lett. 9:1128–1134. 2015.PubMed/NCBI
|
|
9
|
Zhang W, Liu K, Liu S, Ji B, Wang Y and
Liu Y: MicroRNA-133a functions as a tumor suppressor by targeting
IGF-1R in hepatocellular carcinoma. Tumour Biol. 36:9779–9788.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: MiR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang F, Li T, Zhang B, Li H, Wu Q, Yang L,
Nie Y, Wu K, Shi Y and Fan D: MicroRNA-19a/b regulates multidrug
resistance in human gastric cancer cells by targeting PTEN. Biochem
Biophys Res Commun. 434:688–694. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hsu KW, Wang AM, Ping YH, Huang KH, Huang
TT, Lee HC, Lo SS, Chi CW and Yeh TS: Downregulation of tumor
suppressor MBP-1 by microRNA-363 in gastric carcinogenesis.
Carcinogenesis. 35:208–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song JH and Meltzer SJ: MicroRNAs in
pathogenesis, diagnosis and treatment of gastroesophageal cancers.
Gastroenterology. 143:35–47 e32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang J, Li L, Huang W, Sui C, Yang Y, Lin
X, Hou G, Chen X, Fu J, Yuan S, et al: MiR-429 increases the
metastatic capability of HCC via regulating classic Wnt pathway
rather than epithelial-mesenchymal transition. Cancer Lett.
364:33–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu W, He J, Chen D, Zhang B, Xu L, Ma H,
Liu X, Zhang Y and Le H: Expression of miR-29c, miR-93 and miR-429
as potential biomarkers for detection of early stage non-small lung
cancer. PLoS One. 9:e877802014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Said NA and Williams ED: Growth factors in
induction of epithelial-mesenchymal transition and metastasis.
Cells Tissues Organs. 193:85–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun Y, Shen S, Liu X, Tang H, Wang Z, Yu
Z, Li X and Wu M: MiR-429 inhibits cells growth and invasion and
regulates EMT-related marker genes by targeting Onecut2 in
colorectal carcinoma. Mol Cell Biochem. 390:19–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bartis D, Mise N, Mahida RY, Eickelberg O
and Thickett DR: Epithelial-mesenchymal transition in lung
development and disease: Does it exist and is it important? Thorax.
69:760–765. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miyazono K: Transforming growth
factor-beta signaling in epithelial-mesenchymal transition and
progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci.
85:314–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie P, Xu F, Cheng W, Gao J, Zhang Z, Ge
J, Wei Z, Xu X and Liu Y: Infiltration related miRNAs in bladder
urothelial carcinoma. J Huazhong Univ Sci Technolog Med Sci.
32:576–580. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Leskela S, Leandro-Garcia LJ, Mendiola M,
Barriuso J, Inglada-Pérez L, Muñoz I, Martínez-Delgado B, Redondo
A, de Santiago J, Robledo M, et al: The miR-200 family controls
beta-tubulin III expression and is associated with paclitaxel-based
treatment response and progression-free survival in ovarian cancer
patients. Endocr Relat Cancer. 18:85–95. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu X, Liu Y, Wu S, Shi X, Li L, Zhao J
and Xu H: Tumor-suppressing effects of miR-429 on human
osteosarcoma. Cell Biochem Biophys. 70:215–224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Li M, Zang W, Ma Y, Wang N, Li P,
Wang T and Zhao G: MiR-429 up-regulation induces apoptosis and
suppresses invasion by targeting Bcl-2 and SP-1 in esophageal
carcinoma. Cell Oncol (Dordr). 36:385–394. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ye ZB, Ma G, Zhao YH, Xiao Y, Zhan Y, Jing
C, Gao K, Liu ZH and Yu SJ: miR-429 inhibits migration and invasion
of breast cancer cells in vitro. Int J Oncol. 46:531–538.
2015.PubMed/NCBI
|
|
26
|
Sun T, Wang C, Xing J and Wu D: miR-429
modulates the expression of c-myc in human gastric carcinoma cells.
Eur J Cancer. 47:2552–2559. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dynan WS and Tjian R: The
promoter-specific transcription factor Sp1 binds to upstream
sequences in the SV40 early promoter. Cell. 35:79–87. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang
X, Jiang L, Sun Z, Miao Z and Xu H: MicroRNA-335 acts as a
metastasis suppressor in gastric cancer by targeting Bcl-w and
specificity protein 1. Oncogene. 31:1398–1407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yue L, Li L, Liu F, Hu N, Zhang W, Bai X,
Li Y, Zhang Y, Fu L, Zhang X and Ye L: The oncoprotein HBXIP
activates transcriptional coregulatory protein LMO4 via Sp1 to
promote proliferation of breast cancer cells. Carcinogenesis.
34:927–935. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yin P, Zhao C, Li Z, Mei C, Yao W, Liu Y,
Li N, Qi J, Wang L, Shi Y, et al: Sp1 is involved in regulation of
cystathionine gamma-lyase gene expression and biological function
by PI3K/Akt pathway in human hepatocellular carcinoma cell lines.
Cell Signal. 24:1229–1240. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bonofiglio D, Qi H, Gabriele S, Catalano
S, Aquila S, Belmonte M and Andò S: Peroxisome
proliferator-activated receptor gamma inhibits follicular and
anaplastic thyroid carcinoma cells growth by upregulating
p21Cip1/WAF1 gene in a Sp1-dependent manner. Endocr Relat Cancer.
15:545–557. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pathi S, Jutooru I, Chadalapaka G, Nair V,
Lee SO and Safe S: Aspirin inhibits colon cancer cell and tumor
growth and downregulates specificity protein (Sp) transcription
factors. PLoS One. 7:e482082012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang C and Xie K: Crosstalk of Sp1 and
Stat3 signaling in pancreatic cancer pathogenesis. Cytokine Growth
Factor Rev. 23:25–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang YT, Chuang JY, Shen MR, Yang WB,
Chang WC and Hung JJ: Sumoylation of specificity protein 1 augments
its degradation by changing the localization and increasing the
specificity protein 1 proteolytic process. J Mol Biol. 380:869–885.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Black AR, Black JD and Azizkhan-Clifford
J: Sp1 and krüppel-like factor family of transcription factors in
cell growth regulation and cancer. J Cell Physiol. 188:143–160.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li L, He S, Sun JM and Davie JR: Gene
regulation by Sp1 and Sp3. Biochem Cell Biol. 82:460–471. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Safe S and Abdelrahim M: Sp transcription
factor family and its role in cancer. Eur J Cancer. 41:2438–2448.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang L, Guan X, Zhang J, Jia Z, Wei D, Li
Q, Yao J and Xie K: Targeted inhibition of Sp1-mediated
transcription for antiangiogenic therapy of metastatic human
gastric cancer in orthotopic nude mouse models. Int J Oncol.
33:161–167. 2008.PubMed/NCBI
|
|
39
|
Sun L, Liang J, Wang Q, Li Z, Du Y and Xu
X: MicroRNA-137 suppresses tongue squamous carcinoma cell
proliferation, migration and invasion. Cell Prolif. 49:628–635.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu X, Duan H, Zhou S, Liu Z, Wu D, Zhao
T, Xu S, Yang L and Li D: microRNA-199a-3p functions as tumor
suppressor by regulating glucose metabolism in testicular germ cell
tumors. Mol Med Rep. 14:2311–2320. 2016.PubMed/NCBI
|
|
41
|
Guo MM, Hu LH, Wang YQ, Chen P, Huang JG,
Lu N, He JH and Liao CG: miR-22 is down-regulated in gastric cancer
and its overexpression inhibits cell migration and invasion via
targeting transcription factor Sp1. Med Oncol. 30:5422013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Oue N, Aung PP, Mitani Y, Kuniyasu H,
Nakayama H and Yasui W: Genes involved in invasion and metastasis
of gastric cancer identified by array-based hybridization and
serial analysis of gene expression. Oncology. 69 Suppl 1:17–22.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gupta GP and Massague J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Klein CA: Cancer. The metastasis cascade.
Science. 321:1785–1787. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang W, Liu J, Qiu J, Fu X, Tang Q, Yang
F, Zhao Z and Wang H: MicroRNA-382 inhibits prostate cancer cell
proliferation and metastasis through targeting COUP-TFII. Oncol
Rep. 36:3707–3715. 2016.PubMed/NCBI
|
|
46
|
Zhou Q, Zhu Y, Wei X, Zhou J, Chang L, Sui
H, Han Y, Piao D, Sha R and Bai Y: MiR-590-5p inhibits colorectal
cancer angiogenesis and metastasis by regulating nuclear factor
90/vascular endothelial growth factor A axis. Cell Death Dis.
7:e24132016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cui Z and Hu Y: MicroRNA-124 suppresses
Slug-mediated lung cancer metastasis. Eur Rev Med Pharmacol Sci.
20:3802–3811. 2016.PubMed/NCBI
|
|
48
|
Shah MY, Ferrajoli A, Sood AK,
Lopez-Berestein G and Calin GA: microRNA Therapeutics in Cancer -
An Emerging Concept. EBioMedicine. 12:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Naidu S, Magee P and Garofalo M:
MiRNA-based therapeutic intervention of cancer. J Hematol Oncol.
8:682015. View Article : Google Scholar : PubMed/NCBI
|
